Gamma-aminobutyric acid production in black soybean milk by Lactobacillus brevis FPA 3709 and the antidepressant effect of the fermented product on a forced swimming rat model

Despite the prevalence and severe effects of depression, the efficacy of currently available antidepressants is often inconsistent, and many exert undesirable side effects. Administration of food containing gamma-aminobutyric acid (GABA) has been proposed as an alternative treatment for depression. Therefore, this study ferments soy-based milk enriched in GABA and tests its anti-depressant activity in Sprague-Dawley (SD) rats. First, Lactobacillus brevis FPA 3709 isolated from fish intestine was selected for its ability to produce GABA during cultivation in MRS broth with monosodium glutamate (MSG). Second, the conditions (substrate composition and treatment, initial pH, and time and temperature of fermentation) for obtaining the highest synthesis of GABA by the selected microorganism were established. Finally, cooked black soybean milk supplemented with 1% MSG, 1% brown sugar, and 0.1% peptone (without adjusting the initial pH level) was fermented (37 °C, 48 h) by L. brevis FPA 3709. SD rats subjected to a forced swimming test (FST) and fed with fermented black soybean milk showed immobility times that were not significantly different from that of rats administered with fluoxetine, a common antidepressant drug, without exhibiting the side effects of lost appetites and reduced body weight typical of fluoxetine use. Fermented black soybean milk enriched with GABA is a good candidate as an alternative treatment of depression.